The US liquid biopsy market size accounted for US$ 362.82 Mn in 2022 and is projected to reach around USD 1,816.95 Mn by 2032, growing at a CAGR of 17.48% from 2023 to 2032.
The global US liquid biopsy market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the US liquid biopsy market across the globe.
A comprehensive estimate on the US liquid biopsy market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of US liquid biopsy during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2474
US Liquid Biopsy Market Report Scope
|Market Size in 2022||USD 362.82 Million|
|Market Size by 2032||USD 1,816.95 Million|
|Growth Rate from 2023 to 2032||CAGR of 17.48%|
|Forecast Period||2023 to 2032|
|Segments Covered||By Biomarker Types, By Application, By Sample, By End User|
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized US liquid biopsy market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
US Liquid Biopsy Market Players
The report includes the profiles of key US liquid biopsy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area
- ANGLE plc, Biocept Inc.
- Bio-Rad Laboratories Inc.
- Epigenomics AG
- Exact Sciences Corporation
- F. Hoffmann-La Roche AG
- Guardant Health Inc.
- Illumina Inc.
- MDxHealth SA
- Menarini Silicon Biosystems
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
By Biomarker Types
- Circulating Tumor Cells (CTCs)
- Circulating Tumor DNA (CTDNA)
- Extracellular vesicles (EVS)
- Other Biomarkers
- Cancer Therapeutic Application
- Reproductive Health
- Other Therapeutic Application
- Blood Sample
- Urine Sample
By End User
- Hospitals and Laboratories
- Academic and Research Centers
- Other End Users
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on US Liquid Biopsy Market
5.1. COVID-19 Landscape: US Liquid Biopsy Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
220.127.116.11. List of Suppliers
18.104.22.168. List of Buyers
Chapter 8. US Liquid Biopsy Market, By Biomarker Types
8.1. US Liquid Biopsy Market, by Biomarker Types, 2023-2032
8.1.1. Circulating Tumor Cells (CTCs)
22.214.171.124. Market Revenue and Forecast (2023-2032)
8.1.2. Circulating Tumor DNA (CTDNA)
126.96.36.199. Market Revenue and Forecast (2023-2032)
8.1.3. Extracellular vesicles (EVS)
188.8.131.52. Market Revenue and Forecast (2023-2032)
8.1.4. Other Biomarkers
184.108.40.206. Market Revenue and Forecast (2023-2032)
Chapter 9. US Liquid Biopsy Market, By Application
9.1. US Liquid Biopsy Market, by Application, 2023-2032
9.1.1. Cancer Therapeutic Application
220.127.116.11. Market Revenue and Forecast (2023-2032)
9.1.2. Reproductive Health
18.104.22.168. Market Revenue and Forecast (2023-2032)
9.1.3. Other Therapeutic Application
22.214.171.124. Market Revenue and Forecast (2023-2032)
Chapter 10. US Liquid Biopsy Market, By Sample
10.1. US Liquid Biopsy Market, by Sample, 2023-2032
10.1.1. Blood Sample
10.1.1.1. Market Revenue and Forecast (2023-2032)
10.1.2. Urine Sample
10.1.2.1. Market Revenue and Forecast (2023-2032)
10.1.3.1. Market Revenue and Forecast (2023-2032)
Chapter 11. US Liquid Biopsy Market, By End User
11.1. US Liquid Biopsy Market, by End User, 2023-2032
11.1.1. Hospitals and Laboratories
126.96.36.199. Market Revenue and Forecast (2023-2032)
11.1.2. Academic and Research Centers
188.8.131.52. Market Revenue and Forecast (2023-2032)
11.1.3. Other End Users
184.108.40.206. Market Revenue and Forecast (2023-2032)
Chapter 12. US Liquid Biopsy Market, Regional Estimates and Trend Forecast
12.1.1. Market Revenue and Forecast, by Biomarker Types (2023-2032)
12.1.2. Market Revenue and Forecast, by Application (2023-2032)
12.1.3. Market Revenue and Forecast, by Sample (2023-2032)
12.1.4. Market Revenue and Forecast, by End User (2023-2032)
Chapter 13. Company Profiles
13.1. ANGLE plc, Biocept Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bio-Rad Laboratories Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Epigenomics AG
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Exact Sciences Corporation
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. F. Hoffmann-La Roche AG
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Guardant Health Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Illumina Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. MDxHealth SA
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Menarini Silicon Biosystems
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. QIAGEN N.V.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Call: +1 9197 992 333